Ribozymes, a new therapeutic strategy?
Keywords:
Ribozimas. RNA Catalítico. Terapia Génica.Abstract
Ribozymes are RNA molecules endowed with catalytic activity, they are able to cataIyze chemical reactions inside the cells. In their natural environment, most of the described ribozymes carry out processing of other RNA molecule. In contrast to the protein ribonucleases, ribozymes exhibit a high-substrate specificity. This feature is the base for the potential use of ribozymes as specific gene suppressors and therefore to develop new therapeutic agents. The need of new therapeutic strategies is even more significant with the rising of diseases against which the existent drugs and therapies do not show the desirable efficiency. The social repercussions of some diseases of difficult or low probability of control (AIDS, Cancer, etc.), has made more acute the need of looking for altemative treatments. Among the experimental approaches that are being carried out is the direct action on the genetic information responsible of such diseases. On this line, several strategies have emerged in the past few years, mainly based on the use of nucleic acids as specific gene suppressors, e.g. antisense oligonucleotides, ribozymes and triplex helix. The ribozymes would act blocking the transmission of genetic information at the RNA level, mediating destruction of RNA genomes (RNA virus) or mRNAs. A deep understanding of the mechanisms used by these molecules for the recognition and interaction with their RNA substrates as well as of these molecules themselves is necessary for the design and effective application of ribozymes with new specificity. In this work we describe the best characterized catalytic RNAs, as well as the different strategies developed for their use as gene tic suppressors.
Downloads
References
(1) HAMPEL, A., TRlTZ, R.: Biochemistry (1989), 28:4929-4933 .
(2) BERZAL-HERRANZ, A., JOSEPH, S., BURKE, J. M.: Genes Dev (1992), 6:129-134.
(3) WILSON, e., SZOSTAK, J. W.: Nature (1995), 374:777-782.
(4) BERZAL-HERRANZ, A., JOSEPH, S., eHOWRlRA, B. M., BUTeHER, S. E., BURKE, J. M.: EMBO (1993), 12:2567-2574.
Downloads
Published
How to Cite
Issue
Section
License
The articles, which are published in this journal, are subject to the following terms in relation to the rights of patrimonial or exploitation:
- The authors will keep their copyright and guarantee to the journal the right of first publication of their work, which will be distributed with a Creative Commons BY-NC-SA 4.0 license that allows third parties to reuse the work whenever its author, quote the original source and do not make commercial use of it.
b. The authors may adopt other non-exclusive licensing agreements for the distribution of the published version of the work (e.g., deposit it in an institutional telematic file or publish it in a monographic volume) provided that the original source of its publication is indicated.
c. Authors are allowed and advised to disseminate their work through the Internet (e.g. in institutional repositories or on their website) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).